We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

DIASYS DIAGNOSTIC SYSTEMS

Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App





DiaSys Showcases Expanding Reagents and Instrumentation Portfolio at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022

DiaSys Diagnostic Systems (Holzheim, Germany) is showcasing its expanding product portfolio of analyzers and POCT instruments with a special focus on its reagents, at the 73rd AACC Annual Scientific Meeting & Clinical Lab Expo. More...

Vidan Diagnostics (San Antonio, TX, USA), in partnership with Diasys, is also attending the event where it will feature the recently launched next generation Beta-hydroxybutyrate assay used to assist in the determination of diabetic ketoacidosis (DKA).

At the DiaSys AACC 2022 booth, the focus will be on the company’s reagents HDL-c direct FS, LDL-c direct FS, Cystatin C FS, Procalcitonin FS and CRP FS. The company’s innovative new reagents, HDL-c direct FS and LDL-c direct FS, are homogenous assays for direct determination of high-density lipoproteins (HDL) and low-density lipoproteins (LDL). The high quality reagents offer long calibration and onboard stability of up to four months. Combined with wide measuring ranges and good precision at clinical cut-off points, DiaSys assays HDL-c direct FS and LDL-c direct FS are of high value for clinical-chemistry laboratories.

DiaSys Cystatin C FS is an immunturbidemetric assay, which can be applied on a broad range of clinical chemistry analyzers. The assay is characterized by an outstanding analytical sensitivity in addition to superior correlation with nephelometry. It has excellent onboard and calibration stabilities up to 12 weeks and a high prozone security. The standardized test is essential for reliable kidney diagnosis of clinical-chemistry laboratories.

DiaSys Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetric assay with outstanding onboard and calibration stability, providing a convenient workflow on clinical chemistry analyzers. Determinations of PCT in serum and plasma within the measuring range from 0.2 ng/mL to 50 ng/mL can be performed with high precision at clinical cut-off levels for sepsis. The performance is complemented by high tolerance to endogenous interferents and various therapeutics used in sepsis management. Procalcitonin FS shows a good correlation to established methods. Results from ring trials and a publication demonstrate the strengths of the assay.

DiaSys CRP FS is a liquid-stable immunoturbidimetric test with dedicated ready-to-use calibrators and controls. The test results are fully quantitative which allows true differentiation of borderline cases. The test is standardized to the international reference material, has a wide measuring range, high prozone security and excellent correlation to competitor tests. The test is easily applicable to clinical chemistry analyzers with a variety of instrument applications available.

Additionally, DiaSys will demonstrate the respons 940 fully automatic random access analyzer (RAM) with a sample throughput of 400 (640 incl. ISE) tests/hour. Due to durable quartz cuvettes, low reaction volume, maintenance free photometer and intuitively operated software, respons 940 offers the economic use and reliability required in small to medium sized labs. In combination with DiaSys' high quality reagents perfectly matching to respons 940 highest results security and therefore, a minimized number of reruns can be assured.

Vidan’s next generation Beta-hydroxybutyrate assay for reliable ketosis management comprises prefilled reagent kits that make it easy to load directly onto Architect and Beckman AU clinical chemistry systems. Its Lipid Clearing System (LCS) overcomes the burden of lipemia by eliminating turbidity in the sample before a measurement is performed. Its superior stability reduces the frequency of calibration and allows the reagent to stay onboard longer.
 

Related Links:
DiaSys Diagnostic Systems 
Vidan Diagnostics 


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Gold Member
Automated Cell Culture Chemistry Analyzer
BioProfile FLEX2 Basic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.